Covered recipient · General Payments record
SHEENA HENRY
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2023
$1,942.33
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $818.15 | 35 |
| Education | $72.45 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $277.83 | 13 |
| ABBVIE INC. | $254.07 | 8 |
| Janssen Biotech, Inc. | $50.56 | 2 |
| GENZYME CORPORATION | $37.79 | 1 |
| UCB, Inc. | $37.17 | 2 |
| Lilly USA, LLC | $37.03 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.62 | 1 |
| ANI Pharmaceuticals, Inc. | $32.67 | 1 |
| GlaxoSmithKline, LLC. | $30.64 | 1 |
| Mallinckrodt Hospital Products Inc. | $26.01 | 1 |
| Acerta Pharma LLC | $23.33 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.31 | 1 |
| Abbott Laboratories | $15.72 | 1 |
| PFIZER INC. | $14.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.72 | 07/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019396387 | CMS |
| ABBVIE INC. | $20.32 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997466765 | CMS |
| ABBVIE INC. | $18.83 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997466767 | CMS |
| ABBVIE INC. | $3.34 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997466769 | CMS |
| ABBVIE INC. | $2.59 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997466771 | CMS |
| ABBVIE INC. | $30.14 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997466773 | CMS |
| ABBVIE INC. | $27.84 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997466775 | CMS |
| ABBVIE INC. | $123.86 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997466777 | CMS |
| ABBVIE INC. | $27.15 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997466779 | CMS |
| Amgen Inc. | $7.34 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130341 | CMS |
| Amgen Inc. | $23.49 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130305 | CMS |
| Amgen Inc. | $8.50 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130297 | CMS |
| Amgen Inc. | $27.48 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130317 | CMS |
| Amgen Inc. | $72.45 | 02/21/2023 | Education | Undisputed | 01/23/2026 | 1020677765 | CMS |
| Amgen Inc. | $6.31 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130321 | CMS |
| Amgen Inc. | $15.89 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130309 | CMS |
| Amgen Inc. | $13.88 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130325 | CMS |
| Amgen Inc. | $32.57 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130313 | CMS |
| Amgen Inc. | $14.51 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130301 | CMS |
| Amgen Inc. | $18.47 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130329 | CMS |
| Amgen Inc. | $18.47 | 06/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130333 | CMS |
| Amgen Inc. | $18.47 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020130337 | CMS |
| ANI Pharmaceuticals, Inc. | $32.67 | 03/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034173671 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.33 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015272007 | CMS |
| GENZYME CORPORATION | $37.79 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050363531 | CMS |
| GlaxoSmithKline, LLC. | $30.64 | 02/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003344587 | CMS |
| Janssen Biotech, Inc. | $32.09 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988443575 | CMS |
| Janssen Biotech, Inc. | $18.47 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988443585 | CMS |
| Lilly USA, LLC | $19.38 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032347105 | CMS |
| Lilly USA, LLC | $17.65 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032171829 | CMS |
| Mallinckrodt Hospital Products Inc. | $26.01 | 06/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1042839501 | CMS |
| Novartis Pharmaceuticals Corporation | $19.31 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992134357 | CMS |
| PFIZER INC. | $14.85 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050364831 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.62 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055403519 | CMS |
| UCB, Inc. | $21.45 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021843877 | CMS |
| UCB, Inc. | $15.72 | 05/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021843869 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.